NCT07039383View on ClinicalTrials.gov

A Real-world Study of the Effectiveness of Tisagenlecleucel in Acute Lymphoblastic Leukemia Patients

CompletedOBSERVATIONAL
Enrollment

79

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

June 18, 2024

Study Completion Date

June 18, 2024

Conditions
Acute Lymphoblastic Leukemia
Trial Locations (1)

07936

Novartis, East Hanover

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY